# OnCo record nct04325828 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04325828/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04325828", "NCT04325828" ;
  schema:name "A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma"@en ;
  schema:alternateName "YATAGARASU"@en ;
  schema:description "A phase 2 trial of Apalutamide in salivary gland cancers, run by Janssen Pharmaceutical K.K., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04325828/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04325828> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2020-04-07" ;
  onco:cancers <https://onco.cc/cancers/salivary-gland/>, <https://onco.cc/cancers/salivary-duct-carcinoma/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:drugs <https://onco.cc/drugs/apalutamide/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> .